AR119639A1 - ANTIBODY MOLECULES TO CD73 AND THEIR USES - Google Patents

ANTIBODY MOLECULES TO CD73 AND THEIR USES

Info

Publication number
AR119639A1
AR119639A1 ARP180101745A ARP180101745A AR119639A1 AR 119639 A1 AR119639 A1 AR 119639A1 AR P180101745 A ARP180101745 A AR P180101745A AR P180101745 A ARP180101745 A AR P180101745A AR 119639 A1 AR119639 A1 AR 119639A1
Authority
AR
Argentina
Prior art keywords
antibody molecules
bind
treat
disclosed
prevent
Prior art date
Application number
ARP180101745A
Other languages
Spanish (es)
Inventor
Ii Delmas John Venable
Wei Shu
Mikias Woldegiorgis
Dirksen Bussiere
Marie Fjaellskog
- Subramanian Kulandayan Kasi Louise
Pamela Holland
Michael Warren
Rachel W Oconnor
Alison Paterson
Andrew Lake
Scott Chapel
Bianka Prinz
Jerry M Thomas
Glenn Dranoff
Catherine Anne Sabatos-Peyton
Viviana Cremasco
Ansgar Brock
Michael Gladstone
Original Assignee
Novartis Ag
Surface Oncology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag, Surface Oncology Inc filed Critical Novartis Ag
Publication of AR119639A1 publication Critical patent/AR119639A1/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se divulgan moléculas de anticuerpo que se unen a CD73. Las moléculas de anticuerpo anti-CD73 pueden usarse para tratar, prevenir y/o diagnosticar el cáncer.Antibody molecules that bind to CD73 are disclosed. Anti-CD73 antibody molecules can be used to treat, prevent and/or diagnose cancer.

ARP180101745A 2017-06-22 2018-06-22 ANTIBODY MOLECULES TO CD73 AND THEIR USES AR119639A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762523481P 2017-06-22 2017-06-22

Publications (1)

Publication Number Publication Date
AR119639A1 true AR119639A1 (en) 2022-01-05

Family

ID=80633292

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180101745A AR119639A1 (en) 2017-06-22 2018-06-22 ANTIBODY MOLECULES TO CD73 AND THEIR USES

Country Status (1)

Country Link
AR (1) AR119639A1 (en)

Similar Documents

Publication Publication Date Title
CO2019014414A2 (en) Antibody molecules that bind to cd73 and their uses
CL2020001637A1 (en) Antibodies to lilrb2
ECSP16081503A (en) ANTIBODY MOLECULES THAT BIND AND USES LAG-3
CO2018006461A2 (en) Anti-april antibody molecules and uses thereof
GT201800090A (en) ANTIBODIES THAT SPECIFICALLY BIND PD-1 AND ITS USES
CO2017010618A2 (en) Antibodies against icos
ECSP17029218A (en) ANTIBODY MOLECULES THAT BIND AND USES PD-L1
ECSP16068976A (en) ANTIBODY MOLECULES THAT BIND AND USES PD-1
CO2018011364A2 (en) Anti-il-33 antibodies, compositions, methods and uses thereof
MX2020003783A (en) Antibody molecules to cd138 and uses thereof.
ECSP17011657A (en) DRUG CONJUGATES WITH ANTI-CDH6 ANTIBODIES
CR20160347A (en) ANTIBODY MOLECULES THAT JOIN TIM-3 AND USES OF THE SAME
BR112016017112A2 (en) APILIMOD COMPOSITIONS AND METHODS OF USE THEREOF
BR112018012116A2 (en) intravesical therapy for bladder cancer
AR119639A1 (en) ANTIBODY MOLECULES TO CD73 AND THEIR USES
CL2018001661A1 (en) Antibody molecules that bind to tnf alpha
CO2021000349A2 (en) Complement Component 5 Antibody Molecules and Their Uses
AR117579A1 (en) SPECIFIC ANTIBODIES FOR GUCY2C AND ITS USES
AR104081A1 (en) ANTIBODY MOLECULES THAT JOIN PD-L1 AND ITS USES